Predictive value of plasma copeptin level for diagnosis and mortality of pulmonary embolism.

Creative Commons License

Ozmen C., Deveci O. S., Karaaslan M. B., Baydar O., Akray A., Deniz A., ...More

Revista da Associacao Medica Brasileira (1992), vol.66, no.12, pp.1645-1650, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 66 Issue: 12
  • Publication Date: 2020
  • Doi Number: 10.1590/1806-9282.66.12.1645
  • Journal Name: Revista da Associacao Medica Brasileira (1992)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals
  • Page Numbers: pp.1645-1650
  • Keywords: Biomarkers, Death, Pulmonary embolism/diagnosis, Pulmonary embolism/mortality, Arginine vasopressin/metabolism, RISK STRATIFICATION, ARGININE-VASOPRESSIN, STABLE PEPTIDE, PATHOPHYSIOLOGY, QUANTIFICATION, PRECURSOR, IMPACT
  • Çukurova University Affiliated: Yes


OBJECTIVE: Early diagnosis and risk stratification may provide a better prognosis in pulmonary embolism (PE). Copeptin has emerged as a valuable predictive biomarker in various cardiovascular diseases. The aim of this study was to determine the levels of copeptin in patients with acute PE and to evaluate its relationship with disease severity and PE-related death.